These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils. Wall JS, Kennel SJ, Williams A, Richey T, Stuckey A, Huang Y, Macy S, Donnell R, Barbour R, Seubert P, Schenk D. PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743 [Abstract] [Full Text] [Related]
10. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. Wall JS, Kennel SJ, Paulus M, Gregor J, Richey T, Avenell J, Yap J, Townsend D, Weiss DT, Solomon A. J Nucl Med; 2006 Dec 22; 47(12):2016-24. PubMed ID: 17138745 [Abstract] [Full Text] [Related]
11. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy. Wall JS, Williams AD, Foster JS, Richey T, Stuckey A, Macy S, Wooliver C, Campagna SR, Tague ED, Farmer AT, Lands RH, Martin EB, Heidel RE, Kennel SJ. Proc Natl Acad Sci U S A; 2018 Nov 13; 115(46):E10839-E10848. PubMed ID: 30377267 [Abstract] [Full Text] [Related]
12. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis. Poshusta TL, Sikkink LA, Leung N, Clark RJ, Dispenzieri A, Ramirez-Alvarado M. PLoS One; 2009 Nov 13; 4(4):e5169. PubMed ID: 19365555 [Abstract] [Full Text] [Related]
13. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL). Abraham RS, Geyer SM, Ramírez-Alvarado M, Price-Troska TL, Gertz MA, Fonseca R. J Clin Immunol; 2004 Jul 13; 24(4):340-53. PubMed ID: 15163890 [Abstract] [Full Text] [Related]
15. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis. Klimtchuk ES, Prokaeva TB, Spencer BH, Gursky O, Connors LH. Amyloid; 2017 Jun 13; 24(2):115-122. PubMed ID: 28632419 [Abstract] [Full Text] [Related]
17. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation. Kazman P, Vielberg MT, Pulido Cendales MD, Hunziger L, Weber B, Hegenbart U, Zacharias M, Köhler R, Schönland S, Groll M, Buchner J. Elife; 2020 Mar 10; 9():. PubMed ID: 32151314 [Abstract] [Full Text] [Related]
19. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain. Kiyama M, Hoshii Y, Cui D, Kawano H, Kanda T, Ishihara T. Pathol Int; 2007 Jun 10; 57(6):343-50. PubMed ID: 17539965 [Abstract] [Full Text] [Related]